Achilles Therapeutics (ACHL) News Today → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free ACHL Stock Alerts $0.95 +0.03 (+3.57%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 5:00 PM | globenewswire.comAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementMay 12, 2024 | americanbankingnews.comShort Interest in Achilles Therapeutics plc (NASDAQ:ACHL) Drops By 36.5%May 8, 2024 | investorplace.comACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024May 8, 2024 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 8, 2024 | globenewswire.comAchilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsApril 17, 2024 | msn.comAchilles Therapeutics plc - Depositary Receipt () (ACHL) Price Target Decreased by 56.41% to 2.89April 5, 2024 | msn.comPiper downgrades Achilles to neutral, cites latest dataApril 4, 2024 | markets.businessinsider.comACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023April 4, 2024 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | globenewswire.comAchilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | globenewswire.comAchilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host ConditioningApril 1, 2024 | marketbeat.comAchilles Therapeutics (ACHL) to Release Earnings on TuesdayAchilles Therapeutics (NASDAQ:ACHL) will be releasing earnings on Tuesday, April 2, Yahoo Finance reports.March 7, 2024 | finance.yahoo.comWill Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?March 4, 2024 | marketbeat.comAchilles Therapeutics (ACHL) Set to Announce Quarterly Earnings on TuesdayAchilles Therapeutics (NASDAQ:ACHL) will be releasing earnings on Tuesday, March 5, Yahoo Finance reports.February 22, 2024 | wsj.comAchilles Therapeutics PLC ADRFebruary 22, 2024 | benzinga.comAchilles Therapeutics Stock (NASDAQ:ACHL), Short Interest ReportFebruary 9, 2024 | investing.comAchilles Therapeutics PLC ADR (ACHL)February 5, 2024 | finance.yahoo.comAchilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 ConferenceDecember 22, 2023 | benzinga.comAchilles Therapeutics Stock (NASDAQ:ACHL) Dividends: History, Yield and DatesDecember 20, 2023 | seekingalpha.comACHL Achilles Therapeutics plcDecember 18, 2023 | finance.yahoo.comAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity PredictionNovember 22, 2023 | foxnews.comSteelers lose Kwon Alexander for season with torn Achilles: reportsNovember 14, 2023 | msn.comAchilles Therapeutics GAAP EPS of -$0.42 misses by $0.02October 29, 2023 | foxnews.comAs Aaron Rodgers rehabs from torn Achilles, doctor offers insight into recoverySeptember 23, 2023 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementSeptember 22, 2023 | uk.style.yahoo.comAre Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?September 21, 2023 | usatoday.comAaron Rodgers says he's starting 'road to recovery' after Achilles surgery went 'great'September 17, 2023 | usatoday.comJets QB Aaron Rodgers to miss rest of NFL season with torn AchillesSeptember 14, 2023 | dailymail.co.ukAaron Rodgers said he was 'manifesting' a Super Bowl run for the Jets in interview with John McEnroe that aired just MINUTES before he suffered season-ending Achilles injurySeptember 14, 2023 | cbsnews.comAaron Rodgers' Achilles injury is "not good," Jets head coach says, as star quarterback is set to get MRISeptember 6, 2023 | finance.yahoo.comIs KalVista Pharmaceuticals (KALV) Stock Outpacing Its Medical Peers This Year?August 7, 2023 | msn.comChardan Capital Reiterates Achilles Therapeutics Plc - ADR (ACHL) Buy RecommendationAugust 4, 2023 | finance.yahoo.comAchilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsJune 12, 2023 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics to Present at Upcoming ConferencesMay 11, 2023 | msn.comAchilles Therapeutics: Q1 Earnings InsightsMay 10, 2023 | seekingalpha.comAchilles Therapeutics GAAP EPS of -$0.44May 10, 2023 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business HighlightsMay 10, 2023 | finance.yahoo.comAchilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell AntigensMay 10, 2023 | finance.yahoo.comAchilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business HighlightsApril 25, 2023 | finance.yahoo.comAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementApril 25, 2023 | finance.yahoo.comAchilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA StatusApril 17, 2023 | finance.yahoo.comAchilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing SummitMarch 24, 2023 | health.usnews.comGerard Achilles M. ObnialMarch 24, 2023 | dailymail.co.ukMe and my operation: achilles tendon surgeryMarch 7, 2023 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business HighlightsMarch 7, 2023 | finance.yahoo.comAchilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business HighlightsJanuary 17, 2023 | finance.yahoo.comIs Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?December 20, 2022 | finance.yahoo.comAchilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 6, 2022 | finance.yahoo.comAchilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022November 30, 2022 | finance.yahoo.comAchilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022 Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Next President (Not Trump. Not Biden.) (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump. Click here to see why it will be ______ _________. ACHL Media Mentions By Week ACHL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACHL News Sentiment▼0.490.42▲Average Medical News Sentiment ACHL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACHL Articles This Week▼10▲ACHL Articles Average Week Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SABS News PLUR News INKT News BCLI News QNCX News SRZN News CYTH News OKYO News DYAI News INAB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACHL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
